Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma of large intestine
|
432 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Breast Carcinoma
|
2793 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Carcinoma of lung
|
1204 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Colorectal Carcinoma
|
1962 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Colorectal Neoplasms
|
609 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Endometrioid carcinoma ovary
|
35 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of large intestine
|
375 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant tumor of colon
|
688 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
ovarian neoplasm
|
757 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Ovarian Serous Adenocarcinoma
|
65 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Prostate carcinoma
|
1168 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Squamous cell carcinoma of lung
|
283 | 0.701 | 0.280 | 3 | 169043635 | intergenic variant | A/G | snv | 4.2E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 |